GTI
OrganizationRelationship Network
HOUSE_OVERSIGHT_024876.jpg
This document is page 60 of a financial research report titled 'Cowen Collaborative Insights' dated February 25, 2019. It analyzes the financial performance and outlook of CBD companies, specifically highlighting Charlotte's Web (CWEB) and CV Sciences (CVSI) for their strong EBITDA margins and revenue growth. The document includes charts comparing various cannabis/CBD companies (TPB, GTI, TLRY, etc.) and projects significant revenue growth for Charlotte's Web through 2020. The document bears a 'HOUSE_OVERSIGHT_024876' stamp, indicating it was part of a document production for a congressional investigation, likely subpoenaed from Cowen regarding financial records.
HOUSE_OVERSIGHT_024875.jpg
This document is page 59 of a Cowen Collaborative Insights financial report dated February 25, 2019, analyzing the Cannabis/CBD market. It presents comparative financial data (Revenue, Gross Profit, and Gross Margin) for several companies including Charlotte's Web, CV Sciences, and Level Brands. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional investigation document production.
HOUSE_OVERSIGHT_024874.jpg
This document is page 58 of a Cowen Collaborative Insights financial report dated February 25, 2019, analyzing the cannabis and CBD industry. It details strategic updates, retail distribution benchmarking (store counts), and revenue figures for companies including TGOD, HEXO, Neptune, Organigram, Charlotte's Web, and Tilray. While the content is strictly financial analysis, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024874', indicating it was part of a document production for a US House Oversight Committee investigation, likely related to broader financial inquiries.
HOUSE_OVERSIGHT_024872.jpg
This document is a page from a Cowen Collaborative Insights equity research report dated February 25, 2019. It analyzes several companies in the cannabis and tobacco sectors, including GTI, Khiron Life Sciences, Level Brands, Tilray, and Turning Point Brands, providing revenue figures, stock ratings, and acquisition details. The document bears a House Oversight Committee Bates stamp, suggesting it was included in document production for a congressional investigation, likely related to financial institutions, though the page itself contains no direct references to Jeffrey Epstein.
HOUSE_OVERSIGHT_024871.jpg
This document is page 55 of a Cowen financial research report dated February 25, 2019, analyzing the cannabis and CBD market. It details the business models, revenues, and strategies of companies including Curaleaf, CV Sciences, Elixinol, and Green Thumb Industries (Beboe). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was likely produced as part of a congressional investigation, though no specific Epstein connection is mentioned in the text of this page.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity